Jazz Pharmaceuticals JAZZ Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions at other companies
Other financials
Where this comes from
Reported directly by Jazz Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions.
The official record: Jazz Pharmaceuticals’s 10-K, filed February 24, 2026, on SEC EDGAR. View the filing →
Ask your AI about Jazz Pharmaceuticals's unrecognized tax benefits increases resulting from current period tax positions.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Jazz Pharmaceuticals's unrecognized tax benefits increases resulting from current period tax positions?
- Jazz Pharmaceuticals (JAZZ) reported unrecognized tax benefits increases resulting from current period tax positions of $6.13M in Q4 2025.
- How has Jazz Pharmaceuticals's unrecognized tax benefits increases resulting from current period tax positions changed year-over-year?
- Jazz Pharmaceuticals's unrecognized tax benefits increases resulting from current period tax positions decreased by 24.6% year-over-year, from $8.14M to $6.13M.
- What is the long-term trend for Jazz Pharmaceuticals's unrecognized tax benefits increases resulting from current period tax positions?
- Over 4 years (2021 to 2025), Jazz Pharmaceuticals's unrecognized tax benefits increases resulting from current period tax positions has grown at a -2.1% compound annual growth rate (CAGR), from $26.68M to $24.54M.
- What does unrecognized tax benefits increases resulting from current period tax positions mean?
- The amount of new tax uncertainty created by positions taken in the current year's tax filings.
- How do you interpret unrecognized tax benefits increases resulting from current period tax positions?
- An increase suggests more aggressive tax planning or higher complexity in current year operations, while a decrease suggests more conservative tax positioning.
- How does unrecognized tax benefits increases resulting from current period tax positions compare across companies?
- Standard disclosure for multinational corporations under ASC 740, often compared across peers to gauge tax risk appetite.